Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer

Cancer Cell(2020)10.1016/j.ccell.2020.02.008Source: DataRank Database

Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer is a research paper published in Cancer Cell (2020). On theSindex it has a DataRank of 0. It has been cited 461 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access461 citations

Download PDF

Cite:

Linked data & code

geo gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 20.22)OA: bronzeTopics (41)Linked Datasets (20)DataCite Reuse (20)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Varintra E. Krisnawan,Brett H. Herzog ORCID,Chong Zuo ORCID,Marcus Breden ORCID,Brett L. Knolhoff ORCID

Live enrichment

PubMed:32183949 PMC:PMC7181337 OpenAlex:https://openalex.org/W3011819195

NCI NIH HHS

Grant: F99 CA223043

NCI NIH HHS

Grant: K00 CA223043

NCI NIH HHS

Grant: P30 CA091842

NIH HHS

Grant: DP5 OD026427

NCI NIH HHS

Grant: R01 CA177670

NCI NIH HHS

Grant: R01 CA244938

NCRR NIH HHS

Grant: UL1 RR024992

NCI NIH HHS

Grant: P50 CA196510

NCI NIH HHS

Grant: R01 CA181745

NIDDK NIH HHS

Grant: P30 DK052574

NIH HHS

Grant: S10 OD020136

NCI NIH HHS

Grant: R01 CA203890

NCATS NIH HHS

Grant: UL1 TR002345

National Institutes of Health

FWCI

20.22

Citation Percentile

1.0%

Citation Trend

2019

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S1535610820300970/pdf

publisherhttp://www.cell.com/article/S1535610820300970/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610820300970?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610820300970?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2020.02.008

Fields of Study

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesPancreatic and Hepatic Oncology Research

MeSH Terms

Adenocarcinoma of LungAnimalsDendritic CellsHumansImmunotherapyLung NeoplasmsMice, Inbred C57BLMice, Mutant StrainsMice, TransgenicPancreatic NeoplasmsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCarcinoma, Pancreatic DuctalCell Line, TumorMice

Keywords

Pancreatic cancerImmune systemAdenocarcinomaCancer researchTumor microenvironmentImmunityImmunologyMedicineLung cancerCancerTumor progressionMetastasisDendritic cellBiologyPathologyInternal medicineImmunotherapyVaccinationCD40NeoantigenRadiation TherapyImmune SurveillanceFlt3l

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy

10.6084/m9.figshare.21321506.v1figshare

Additional file 1 of Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy

10.6084/m9.figshare.21321506figshare

Additional file 2 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.25556642.v1figshare

Additional file 2 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.25556642figshare

Additional file 4 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702515.v1figshare

Additional file 4 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702515figshare

Additional file 5 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702518.v1figshare

Additional file 5 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702518figshare

Additional file 6 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702521.v1figshare

Additional file 6 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702521figshare

Additional file 7 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702524.v1figshare

Additional file 7 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702524figshare

Additional file 8 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702527.v1figshare

Additional file 8 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702527figshare

Additional file 9 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702533.v1figshare

Additional file 9 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702533figshare

Additional file 3 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702512figshare

Additional file 3 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.26702512.v1figshare

Additional file 1 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.25556573.v1figshare

Additional file 1 of Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis

10.6084/m9.figshare.25556573figshare

Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer

FAIR Checklist

Authors (19)

Funding (14 grants)

Impact

Open Access

Topics

Linked Datasets (20)

Annotations (Europe PMC)